問卷

TPIDB > Principal Investigator

Principal Investigator


Taipei Medical University Hospital (在職)

Division of Gastroenterological Surgery

Division of General Surgery

更新時間:2023-09-19

王偉Wang, Weu
  • Principal Investigator
  • Clinical Trial Experience (year) 12 years 9 個月

篩選

List

2Cases

2023-09-15 - 2025-10-22

Phase III

Completed
Efficacy and safety of semaglutide 2.4 mg once-weekly in adults with overweight and obesity (STEP 12)
  • Condition/Disease

    overweight and obesity

  • Test Drug

    injection

Participate Sites
5Sites

Recruiting5Sites

2023-09-15 - 2025-10-22

Phase III

Efficacy and safety of semaglutide 2.4 mg once-weekly in adults with overweight and obesity (STEP 12)
  • Condition/Disease

    overweight and obesity

  • Test Drug

    Semaglutide B

Participate Sites
5Sites

Not yet recruiting2Sites

Terminated3Sites